Mgo One Seven LLC Horizon Therapeutics Public LTD CO Transaction History

Mgo One Seven LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$62.39 - $113.8 $26,827 - $48,934	-430 Reduced 5.43%	7,482 $0
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $22,507 - $32,343	-382 Reduced 4.61%	7,912 $489,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $25,487 - $37,351	-321 Reduced 3.73%	8,294 $662,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $35,172 - $44,692	-407 Reduced 4.51%	8,615 $906,000
Q4 2021 Feb 09, 2022	BUY	$98.56 - $119.91 $5,913 - $7,194	60 Added 0.67%	9,022 $972,000

Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $40,991 - $49,225	-446 Reduced 4.74%	8,962 $1.08 Million
Q2 2021 Jul 29, 2021	SELL	$86.24 - $95.92 $10,866 - $12,085	-126 Reduced 1.32%	9,408 $881,000
Q1 2021 Apr 29, 2021	SELL	$71.83 - $95.48 $3,232 - $4,296	-45 Reduced 0.47%	9,534 $877,000
Q4 2020 Jan 22, 2021	SELL	$67.0 - $84.39 $15,410 - $19,409	-230 Reduced 2.34%	9,579 $701,000
Q3 2020 Oct 30, 2020	SELL	$55.23 - $79.93 $22,975 - $33,250	-416 Reduced 4.07%	9,809 $762,000
Q2 2020 Aug 12, 2020	BUY	$30.2 - $56.98 $308,795 - $582,620	10,225 New	10,225 $568,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.